Dr. Ali R. Ghasemzadeh, MD

Dr. Ghasemzadeh practices at Meadowview Regional Medical Center in Maysville, Kentucky, part of Lifepoint Health.

Dr. Ghasemzadeh's NPI, 1710096839, was assigned on August 30, 2006. Dr. Ghasemzadeh holds Ohio license 35080480.

Dr. Ghasemzadeh's primary practice is Meadowview Regional Medical Center, at 989 Medical Park Drive, Maysville, KY 41056 in Mason County. The practice phone is (606) 759-5311.

Dr. Ghasemzadeh's primary practice is Meadowview Regional Medical Center in Maysville, Kentucky, part of Lifepoint Health. Dr. Ghasemzadeh is also affiliated with The Christ Hospital. Dmand AI also links Dr. Ghasemzadeh to 1 more hospital and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ghasemzadeh practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Ghasemzadeh's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Ghasemzadeh's licenses on file in 2 states: Ohio and Kentucky.

CMS data shows 2,401 Medicare services from Dr. Ghasemzadeh across 15 procedure codes in 2024, for 210 Medicare patients. Medicare paid $131,437 for them.

CMS counts 210 Medicare patients who saw Dr. Ghasemzadeh in 2024. The largest group is 65 to 74, with 87 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ghasemzadeh's median patient age at 71, with 58% women.

In 2024, Dr. Ghasemzadeh wrote 3,976 Medicare Part D claims for 348 patients. 88% of them were for generic drugs. CMS names the drug for 3,813 of them, across 48 drugs with 11 or more claims each, at $386,546 in total drug cost. In 2023, CMS named 3,494 claims across 44 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 20 out of 100 for Dr. Ghasemzadeh for performance year 2024, reported individually. Dr. Ghasemzadeh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 57 papers to Dr. Ghasemzadeh, published from 2010 to 2025. 2016 was the busiest year, with 8. The most frequent topics are Antioxidants, Flavonoids and Plant Extracts. Dr. Ghasemzadeh has published most often in Molecules. Dr. Ghasemzadeh's most frequent co-authors are Amir Hossein Dorafshar, MD, Charles George Drake, MD and Gerhard Salomo Mundinger, MD.

CMS Open Payments shows 102 general payments to Dr. Ghasemzadeh from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $610.